Condition: Atrial Septal Defect · Sponsor: Lifetech Scientific (Shenzhen) Co., Ltd.
The objective of this post-market study is to: * collect real-word clinical data and confirm the long-time safety and performance of the Lifetech Cera™ ASD Occluder * identify previously unknown side-effects
This description comes directly from the study's public registry record.
KaDirr Shemsi · +86-176-2130-9203 · kadirr@lifetechmed.com
Jiaxuan Fu · 86+13973207184 · fujiaxuan@lifetechmed.com
Always discuss trial participation with your own doctor first.
| G.V.M.Carint Hospital | Myszków, Poland | Not Yet Recruiting |
| Centre for Invasive Cardiology, Electrotherapy and Angiology G.V.M.Carint-Oswiecim | Oświęcim, Poland | Not Yet Recruiting |
| Subcarpathian Centre for Cardiovascular Intervention G.V.M.Carint -Sanok | Sanok, Poland | Not Yet Recruiting |
| Polish-American Heart Clinics, Heart and Vascular Center in Tychy, American Heart of Poland Group | Tychy, Poland | Recruiting |
| Polish-American Heart Clinics 1st Department of Invasive Cardiology and Heart Failure in Ustroń, AHoP Group | Ustroń, Poland | Not Yet Recruiting |
| Dr. Tytus Chałubiński County Hospital | Zakopane, Poland | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06849635